Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625

Disease

Cancer 3 | 2,346
Cocaine-Related Disorders 3 | 88
Epilepsy 3 | 346
Pain agnosia 3 | 99
Parkinson's disease 3 | 364
Withdrawal disorder 3 | 19
psoriasis 3 | 6,685
Alcohol dependence 2 | 107
Alzheimer's disease 2 | 644
Amnestic disorder 2 | 37
Amphetamine-Related Disorders 2 | 74
Anxiety Disorders 2 | 37
Arthritis 2 | 248
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hypertension 2 | 287
Irritable bowel syndrome 2 | 59
Migraine 2 | 79
Narcolepsy 2 | 58
Obesity 2 | 616
Schizophrenia 2 | 501
Seizures 2 | 95
Toxic encephalopathy 2 | 131
astrocytoma 2 | 1,493
diabetes mellitus 2 | 1,663
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Acne 1 | 20
Alcoholic Intoxication, Chronic 1 | 41
Allergic hypersensitivity disease 1 | 123
Amnesia 1 | 17
Anoxia 1 | 33
Anxiety disorder 1 | 22
Atherosclerosis 1 | 275
Autistic Disorder 1 | 320
Autosomal dominant cerebellar ataxia 1 | 34
Bradycardia 1 | 24
Cardiovascular system disease 1 | 194
Cerebellar Ataxia 1 | 72
Cerebrovascular disease 1 | 231
Cholestasis 1 | 93
Cocaine dependence 1 | 24
Complex regional pain syndrome 1 | 12
Cystitis 1 | 16
Dementia 1 | 129
Dermatitis 1 | 107
Down syndrome 1 | 548
Dyskinesia, Drug-Induced 1 | 15
Eating disorder 1 | 24
Epicondylitis 1 | 19
Eye disease 1 | 55
Fibromyalgia 1 | 22
Fibrous dysplasia 1 | 15
Friedreich ataxia 1 | 23
Gastrointestinal system disease 1 | 50
Heat Stroke 1 | 12
Hemorrhage 1 | 18
Hepatitis C 1 | 90
Hyperalgesia 1 | 71
Hypertensive disease 1 | 193
Hypoglycemia 1 | 81
Hypotension 1 | 53
Infarction, Middle Cerebral Artery 1 | 25
Inflammatory bowel disease 1 | 142
Kidney disease 1 | 396
Lipoatrophic Diabetes Mellitus 1 | 5
Liver carcinoma 1 | 217
Lung Neoplasms 1 | 171
Major Depressive Disorder 1 | 106
Mammary Neoplasms 1 | 410
Morphine dependence 1 | 19
Motion sickness 1 | 32
Movement Disorders 1 | 21
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Neurotoxicity Syndromes 1 | 26
Opiate dependence 1 | 12
Osteitis Fibrosa Disseminata 1 | 2
Osteopetrosis 1 | 40
Osteoporosis 1 | 257
Pain 1 | 70
Parkinsonian Disorders 1 | 23
Reperfusion Injury 1 | 84
Respiratory Insufficiency 1 | 11
Rhinitis 1 | 46
Rosacea 1 | 18
Shipyard eye 1 | 14
Status Epilepticus 1 | 85
Substance Withdrawal Syndrome 1 | 52
Substance abuse 1 | 55
Sudden infant death syndrome 1 | 33
Urticaria 1 | 53
Vascular disease 1 | 281
breast carcinoma 1 | 1,614
chronic kidney disease 1 | 90
fascioscapulohumeral muscular dystrophy 1 | 100
glioblastoma multiforme 1 | 347
medulloblastoma 1 | 1,524
nervous system disorder 1 | 53
post-traumatic stress disorder 1 | 45
pterygium 1 | 74

Tissue

Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Nervous System 3 | 18,561
Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Non-IDG 2 | 11,971
Transcription Factor 1 | 1,400

Grant Application

1R21DA015439-01 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
Proenkephalin-B PDYN Tbio Non-IDG -3.47467 2966.3 161
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86